0.449
8.72%
0.036
Hcw Biologics Inc Stock (HCWB) Forecast
The Hcw Biologics Inc (HCWB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.6167, representing a +37.36% increase from the current price of $0.449. The highest analyst price target is $1.1871, and the lowest is $0.0464.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HCWB Price Target
Average 0.6026
(+34.21% Upside)
Is Hcw Biologics Inc (HCWB) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 49.33 | Neutral |
STOCH(9,6) | 46.31 | Neutral |
STOCHRSI(14) | 100.00 | Sell |
MACD(12,26) | -0.0383 | Sell |
ADX(14) | 35.25 | Buy |
William %R | -32.11 | Neutral |
CCI(14) | 15.72 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
0.3897
Buy
|
0.4109
Buy
|
MA20 |
0.4511
Sell
|
0.4418
Buy
|
MA50 |
0.4952
Sell
|
0.4875
Sell
|
MA100 |
0.5126
Sell
|
0.5679
Sell
|
MA200 |
0.8408
Sell
|
0.775
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, HCWB could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 9 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on HCWB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 49.33 indicates that HCWB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 46.31 indicates that HCWB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that HCWB is oversold. This suggests that HCWB price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 35.25 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 15.72 indicates that HCWB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term HCWB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Hcw Biologics Inc financial reports and earnings history, Hcw Biologics Inc (HCWB) stock could reach $0.8692 by 2030, $9.0326 by 2040 and $11.82 by 2050. See the projected annual prices until 2050 of the Hcw Biologics Inc stock below:
- Hcw Biologics Inc (HCWB) is expected to reach an average price of $4.6937 in 2035, with a high prediction of $4.1867 and a low estimate of $4.2297. This indicates an $945.36% rise from the last recorded price of $0.449.
- Hcw Biologics Inc (HCWB) stock is projected to chart a bullish course in 2040, with an average price target of $9.2426, representing an $1,958% surge from its current level. The forecast ranges from a conservative $9.1421 to a sky-high $9.0326.
- Our analysts predict Hcw Biologics Inc (HCWB) to jump 1,252% by 2045, soaring from $6.072 to an average price of $6.072, potentially reaching $6.0958. While $6.072 is the low estimate, the potential upside is significant.
- Hcw Biologics Inc (HCWB) stock is expected to climb by 2050, reaching an average of $11.77, a $2,522% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.82 and $11.80, respectively, highlighting the market's uncertainty.
Hcw Biologics Inc Stock (HCWB) Year by Year Forecast
Hcw Biologics Inc Stock (HCWB) Price Forecast for 2025
Hcw Biologics Inc Stock (HCWB) is expected to reach an average price of $0.6026 in 2025, with a high prediction of $1.1871 and a low estimate of $0.0181. This indicates an +34.21% rise from the last recorded price of $0.449.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $0.0236 | $0.0464 | $1.1871 | -94.74% |
February, 2025 | $0.2501 | $0.0181 | $0.4719 | -44.29% |
March, 2025 | $0.3266 | $0.0584 | $0.8284 | -27.25% |
April, 2025 | $0.5623 | $0.157 | $0.814 | +25.23% |
May, 2025 | $0.8088 | $0.0586 | $0.9588 | +80.13% |
June, 2025 | $0.6853 | $0.5879 | $1.0353 | +52.62% |
July, 2025 | $0.4509 | $0.3544 | $1.0035 | +0.43% |
August, 2025 | $0.5074 | $0.40 | $0.7292 | +13.01% |
September, 2025 | $0.5739 | $0.4039 | $0.6865 | +27.82% |
October, 2025 | $0.4896 | $0.2005 | $0.5631 | +9.03% |
November, 2025 | $0.3861 | $0.3861 | $0.6478 | -14.02% |
December, 2025 | $0.2917 | $0.2143 | $0.5029 | -35.03% |
Hcw Biologics Inc Stock (HCWB) Price Forecast for 2026
The predicted value for Hcw Biologics Inc (HCWB) in 2026 is set at an average of $0.507. Estimates vary from a peak of $1.0125 to a trough of $0.00154, indicating an +12.92% surge from the present price of $0.449.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $0.0818 | $0.16 | $0.33 | -81.78% |
February, 2026 | $0.05 | $0.0653 | $0.1656 | -88.87% |
March, 2026 | $0.0711 | $0.0022 | $0.1821 | -84.16% |
April, 2026 | $0.7569 | $0.0166 | $0.9269 | +68.57% |
May, 2026 | $0.8034 | $0.656 | $1.0034 | +78.92% |
June, 2026 | $0.7199 | $0.4699 | $1.0125 | +60.33% |
July, 2026 | $0.5155 | $0.5155 | $0.8881 | +14.81% |
August, 2026 | $0.702 | $0.5246 | $0.9739 | +56.35% |
September, 2026 | $0.5276 | $0.3976 | $0.9511 | +17.52% |
October, 2026 | $0.0442 | $0.1383 | $0.7659 | -90.17% |
November, 2026 | $0.0307 | $0.00154 | $0.5443 | -93.17% |
December, 2026 | $0.0663 | $0.0298 | $0.2489 | -85.23% |
Hcw Biologics Inc Stock (HCWB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Hcw Biologics Inc (HCWB) is $1.3243, with a high forecast of $2.5731 and a low forecast of $0.0754. This indicates an +194.94% increase from the last price of $0.449.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $0.1828 | $0.0754 | $0.1828 | -59.29% |
February, 2027 | $0.5693 | $0.1219 | $0.6398 | +26.80% |
March, 2027 | $0.6859 | $0.4576 | $0.8683 | +52.77% |
April, 2027 | $0.5215 | $0.4116 | $1.0332 | +16.14% |
May, 2027 | $1.4799 | $0.3906 | $1.3199 | +229.60% |
June, 2027 | $1.2086 | $1.4486 | $2.5731 | +169.18% |
July, 2027 | $1.5156 | $1.5621 | $1.4656 | +237.55% |
August, 2027 | $1.8126 | $1.8074 | $1.7067 | +303.70% |
September, 2027 | $2.1711 | $1.9843 | $1.9413 | +383.55% |
October, 2027 | $1.8883 | $1.8883 | $2.0231 | +320.56% |
November, 2027 | $1.8753 | $1.9653 | $1.9001 | +317.66% |
December, 2027 | $0.834 | $1.174 | $1.827 | +85.75% |
Hcw Biologics Inc Stock (HCWB) Price Forecast for 2028
In 2028, Hcw Biologics Inc (HCWB) is projected to reach an average price of $1.4037, with a high projection of $1.708 and a low estimate of $1.0994. This indicates an +212.63% rise from the last price of $0.449.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $1.851 | $1.3158 | $1.5203 | +312.25% |
February, 2028 | $1.758 | $1.8479 | $1.708 | +291.54% |
March, 2028 | $1.5467 | $1.7467 | $1.5797 | +244.48% |
April, 2028 | $1.2937 | $1.442 | $1.5285 | +188.13% |
May, 2028 | $0.9825 | $1.3755 | $1.2508 | +118.81% |
June, 2028 | $1.0694 | $1.0994 | $0.8559 | +138.18% |
July, 2028 | $1.2064 | $1.2529 | $1.0727 | +168.69% |
August, 2028 | $1.1652 | $1.1616 | $1.0699 | +159.50% |
September, 2028 | $1.0621 | $1.1796 | $1.0654 | +136.56% |
October, 2028 | $1.2843 | $1.2539 | $1.1891 | +186.04% |
November, 2028 | $1.1679 | $1.1061 | $1.0709 | +160.10% |
December, 2028 | $1.1898 | $1.1442 | $1.1131 | +165.00% |
Hcw Biologics Inc Stock (HCWB) Price Forecast for 2029
The 2029 price forecast for Hcw Biologics Inc Stock (HCWB) is $0.9008 on average, with a high prediction of $1.4023 and a low estimate of $0.3993. This represents an +100.63% increase from the previous price of $0.449.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $1.5536 | $1.2466 | $1.3736 | +246.01% |
February, 2029 | $1.4853 | $1.5006 | $1.3706 | +230.79% |
March, 2029 | $1.3276 | $1.3458 | $1.4023 | +195.69% |
April, 2029 | $0.6745 | $1.1244 | $1.141 | +50.23% |
May, 2029 | $0.5133 | $0.5232 | $0.4263 | +14.31% |
June, 2029 | $0.5603 | $0.465 | $0.4585 | +24.78% |
July, 2029 | $0.6772 | $0.5237 | $0.5412 | +50.83% |
August, 2029 | $0.496 | $0.3993 | $0.609 | +10.46% |
September, 2029 | $0.723 | $0.5412 | $0.4422 | +61.01% |
October, 2029 | $1.0717 | $0.7464 | $1.0617 | +138.68% |
November, 2029 | $1.0487 | $1.0587 | $1.0164 | +133.56% |
December, 2029 | $0.9057 | $0.9857 | $0.8817 | +101.71% |
Hcw Biologics Inc Stock (HCWB) Price Forecast for 2030
Hcw Biologics Inc Stock (HCWB) is expected to reach an average price of $2.1806 in 2030, with a high forecast of $4.1246 and a low forecast of $0.2366. This signifies an +385.66% surge from the last price of $0.449.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $0.8144 | $0.8844 | $0.8692 | +81.38% |
February, 2030 | $0.3914 | $0.4686 | $0.7761 | -12.83% |
March, 2030 | $0.0984 | $0.2366 | $0.1349 | -78.09% |
April, 2030 | $0.3754 | $0.2936 | $0.1364 | -16.38% |
May, 2030 | $3.7548 | $0.467 | $3.5948 | +736.27% |
June, 2030 | $2.2253 | $4.1701 | $3.8301 | +395.62% |
July, 2030 | $3.7084 | $3.6779 | $3.6584 | +725.93% |
August, 2030 | $3.9689 | $3.991 | $3.863 | +783.94% |
September, 2030 | $4.3394 | $4.1315 | $3.8041 | +866.45% |
October, 2030 | $3.9625 | $3.9625 | $4.1246 | +782.51% |
November, 2030 | $3.9129 | $4.0029 | $3.9651 | +771.48% |
December, 2030 | $3.0484 | $3.3758 | $3.8556 | +578.94% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):